Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244664 | SCV000307085 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000462124 | SCV000558183 | benign | Familial focal epilepsy with variable foci | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711426 | SCV000841791 | benign | not provided | 2018-05-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311366 | SCV000846968 | benign | Inborn genetic diseases | 2016-03-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000711426 | SCV001884674 | benign | not provided | 2019-07-24 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000711426 | SCV005275461 | benign | not provided | criteria provided, single submitter | not provided |